Celgene Corp (CELG)

Activist Keith Meister Says This Year’s Market Rally and Last December’s Sell-Off Made Us Break Even

In a yesterdays’ CNBC “Squawk Box” program, Corvex Management’s Keith Meister was a guest and he shared his views on the current and the future......(read more)

April 3 - Hedge Funds, News - Comments

Covalis Capital's Returns, AUM and Holdings

Hedge Fund and Insider Trading News: Seth Klarman, John Paulson, Ray Dalio, Elliott Management, Starboard Value, HD Supply Holdings Inc (HDS), CBAK Energy Technology Inc (CBAT), and a lot More

Billionaire Hedge Fund Manager Klarman Issues Dire Warning on Global Economy (CNBC) Seth Klarman, a hedge fund billionaire some call the next Warren Buffett......(read more)

January 22 - Hedge Funds, Insider Trading - Comments

Rock Springs Capital Management’s Top 5 Largest Stock Picks

Rock Springs Capital Management is a Baltimore-based hedge fund founded in February 2013 by Kris Jenner. Prior to that, Jenner had spent 14 years working......(read more)

February 24 - Hedge Funds, News - Comments

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): Revelations From This Blazing Biotech

Blazing. Sizzling. On fire. They all describe Celgene Corporation (NASDAQ:CELG) pretty well these days. With all of the heat generated by this biotech......(read more)

September 16 - News - Comments

Celgene Corporation (CELG), Bristol-Myers Squibb Co (BMY): One Drug Dramatically Reshaping Pancreatic Cancer Treatment

A couple months may not seem like a long time, but when you’re diagnosed with pancreatic cancer, the prospect of a few months makes a huge difference......(read more)

September 13 - Dividend Stocks, News - Comments

Incyte Corporation (INCY), Pfizer Inc. (PFE): This Biotech Has So Many Reasons to Be Liked

Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only......(read more)

September 6 - News - Comments

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): When Will the Good News End for This Biotech?

They say that bad news comes in threes. I’m not sure if there’s a similar saying for good news, but for Celgene Corporation (NASDAQ:CELG)......(read more)

September 5 - News - Comments

Pharmacyclics, Inc. (PCYC), Johnson & Johnson (JNJ): The FDA Loves This Drug

It should come as no surprise to anyone that the Food and Drug Administration granted a priority review for Pharmacyclics, Inc. (NASDAQ:PCYC) and Johnson......(read more)

September 3 - News - Comments

Celgene Corporation (CELG), Cytokinetics, Inc. (CYTK), Astex Pharmaceuticals, Inc. (ASTX): Is the Biotech Bubble About to Burst?

“Bubble” can be a provocative word in investing circles. Think of all that comes to mind when you hear it — perhaps other words like......(read more)

August 27 - News - Comments

Amgen, Inc. (AMGN), AstraZeneca plc (ADR) (AZN): What’s the Big Deal About Onyx Pharmaceuticals, Inc. (ONXX) Anyway?

At the end of June, Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) announced that it had rejected an offer from Amgen, Inc. (NASDAQ:AMGN) that valued the......(read more)

August 24 - News - Comments

Exelixis, Inc. (EXEL), Vertex Pharmaceuticals Incorporated (VRTX), Celgene Corporation (CELG): Want Multibaggers? Consider These 3 Biotech Companies

In after hours trading on April 18, a few hours after the release of my previous article focusing on Exelixis, Inc. (NASDAQ:EXEL), Vertex Pharmaceuticals......(read more)

August 23 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): Celgene Corporation (CELG)’s Multiple Myeloma Powerhouse

Earlier this month, biotech powerhouse Celgene Corporation (NASDAQ:CELG) announced that the European Commission approved the combinational therapy of......(read more)

August 22 - News - Comments

Pharmacyclics, Inc. (PCYC), Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): This Small Company Is Winning the War Against Blood Cancer

About 15,680 Americans are diagnosed with chronic lymphocytic leukemia, or CLL, and approximately 5,000 new cases of mantle cell lymphoma, or MCL, occur......(read more)

August 21 - News - Comments

Novartis AG (ADR) (NVS), Amgen, Inc. (AMGN): Incyte Corporation (INCY) Jumps on Jakafi Results

Incyte Corporation (NASDAQ:INCY) today announced positive results from a phase 2 study of its drug Jakafi in treating refractory metastatic pancreatic......(read more)

August 21 - News - Comments

Visa Inc (V), Apple Inc. (AAPL): Capital Gains Today, Dividend Growth Tomorrow

One of the traits an investor should have is an ability to display forward-thinking. It is always better to see whats next instead of what has already......(read more)

August 12 - News - Comments

Celgene Corporation (CELG), Compugen Ltd. (USA) (CGEN): This Week in Biotech

With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)

August 12 - News - Comments

Agios Pharmaceuticals Inc (AGIO), Heat Biologics Inc (HTBX), Cellular Dynamics International Inc (ICEL): Are These Three Recent Biotech IPOs Worth Buying?

2013 has been a banner year for biotech IPOs. Over the past two weeks, three major biotechs — Agios Pharmaceuticals Inc (NASDAQ:AGIO), Heat Biologics......(read more)

August 7 - News - Comments

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

Celgene Corporation (CELG), Novartis AG (ADR) (NVS): Momenta Pharmaceuticals, Inc. (MNTA) Earnings Remind Investors of Growing Pains

The investing waters can get pretty choppy from time to time with a developmental stage company. A look at the five-year chart of Momenta Pharmaceuticals......(read more)

August 2 - News - Comments

3 Things You Need to Know From Astex Pharmaceuticals, Inc. (ASTX)’s Q2 Earnings

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) announced its second-quarter financial results on Thursday prior to the market open. The company reported a......(read more)

August 2 - News - Comments

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Celgene Corporation (CELG): Biotech Favorites With Noteworthy Drug Data

Three of the biggest names in biotechnology have reported earnings, and their quarters involved very important drug-related information for investors.......(read more)

July 29 - News - Comments

Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Have You Considered Biotech Yet?

We are in the midst of the earnings season, my favorite time of the year. Some of the largest and most powerful publicly traded firms have already reported......(read more)

July 29 - News - Comments

Celgene Corporation (CELG): Has Multiple Myeloma Met its Match?

Multiple myeloma is a cancer of plasma cells, a type of white blood cell present in bone marrow. This cancer can lead to abnormally high calcium levels......(read more)

July 26 - News - Comments

Three Things You Need to Know From Celgene Corporation (CELG)’s Q2 Earnings

Celgene Corporation (NASDAQ:CELG) did it again. Investors have grown accustomed to the company reporting solid numbers with its earnings announcements......(read more)

July 26 - News - Comments

Amgen, Inc. (AMGN), Celgene Corporation (CELG): Is Big Biotech Still Growing?

The first half of 2013 has seen remarkable growth in the biotech sector, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) up >40% YTD......(read more)

July 24 - News - Comments

Celgene Corporation (CELG): Does This BiotechStudy Matter to You?

Note: This article has been amended to remove the specifics of the Questcor investigation. Motley Fool apologizes for the error. Celgene Corporation (......(read more)

July 23 - News - Comments

Celgene Corporation (CELG): Does This BiotechStudy Matter to You?

Celgene Corporation (NASDAQ:CELG) fell 2.6% on Thursday after disappointing clinical data for its blood cancer drug Revlimid. Investors don’t appear......(read more)

July 22 - News - Comments

Celgene Corporation (CELG): Expanding Labels to Expand Margins

In an industry where buyouts are commonplace and small-cap biotechs burn through cash rapidly, optimizing operating cash flow can be essential to a company......(read more)

July 19 - News - Comments

Celgene Corporation (CELG): Can This Biotech Go Even Higher?

Celgene Corporation (NASDAQ:CELG) has emerged as the leading treatment provider for blood cancer. The company value has almost doubled in the last year......(read more)

July 19 - News - Comments

What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?

Early this morning, Celgene Corporation (NASDAQ:CELG) announced that it was discontinuing the phase 3 ORIGIN Trial evaluating Revlimid (lenalidomide)......(read more)

July 18 - News - Comments

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): A Fundamentally Strong Biotech Stock

Celgene Corporation (NASDAQ:CELG) surged 7% on Thursday, July 11, 2013 on news that the Phase III trials of Revlimid /dexamethasone combination showed......(read more)

July 18 - News - Comments

Pharmacyclics, Inc. (PCYC): Will This Be the Breakthrough of All Breakthrough Therapy Drugs?

In July 2012, the Food and Drug Administration Safety and Innovation Act was signed into law; and little did we know at the time, but the drug development......(read more)

July 12 - News - Comments

Revlimid Results Rev Up Celgene Corporation (CELG)

Good news seems to find its way to Celgene Corporation (NASDAQ:CELG)‘s door frequently these days. The company announced positive results today......(read more)

July 11 - News - Comments

Who Could Buy Onyx Pharmaceuticals, Inc. (ONXX) and at What Price?

Recently Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) rejected a $10 billion takeover offer from Amgen, Inc. (NASDAQ:AMGN). However, after that it hired an......(read more)

July 10 - News - Comments

Biogen Idec Inc. (BIIB), Celgene Corporation (CELG), Gilead Sciences, Inc. (GILD): 3 of Biotech’s Best

It’s been a healthy year-to-date for the biotech sector, with the space logging huge gains above and beyond those of the broad based market. Industry......(read more)

July 10 - News - Comments

Amgen, Inc. (AMGN), Celgene Corporation (CELG), Biogen Idec Inc. (BIIB): Watch Out for These 3 Biotech Companies

The growth of the biotechnology industry is greatly influenced by research and development expenditure. This year, the North American players in the biotechnology......(read more)

July 5 - News - Comments

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Is This Biopharmaceutical Stock Still a Buy?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) has recently experienced a significant jump of nearly 51.3% in only one trading day from $86.82 per share to $......(read more)

July 5 - News - Comments

Starbucks Corporation (SBUX), Celgene Corporation (CELG), LinkedIn Corp (LNKD): Top 10 Performing Large Cap Stocks Through First Half of 2013

As the first half of 2013 ends, let’s look at the year-to-date top performing (and profitable) large cap stocks. Our goal is to identify some winners......(read more)

July 5 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX) Bidding Wars: Who Would Be the Best Suitor?

A lot of activity is happening in the biotech industry which would change the dynamics of the large cancer related drug makers. Recently, Amgen, Inc. (......(read more)

July 3 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX) Says the Price Isn’t Right

Sorry, Bob Barker and Drew Carey — the price isn’t right. That’s the message from Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) over the......(read more)

July 2 - News - Comments

Ariad Pharmaceuticals, Inc. (ARIA), VIVUS, Inc. (VVUS): Winning Biotech Investment Strategies and Their Potential Pitfalls

Investing in biotech companies isn’t without its challenges, but it doesn’t have to be a shot in the dark, either. With a little bit of study......(read more)

June 27 - News - Comments

Posts Tagged ‘Celgene Corp (CELG)’